This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Sima Therapeutics, Inc., Sirna Therapeutics, Inc.. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Norihiro Ikemoto: Innovator in Oligonucleotide Delivery Systems
Introduction
Norihiro Ikemoto is a notable inventor based in Rahway, NJ (US), recognized for his contributions to the field of oligonucleotide delivery systems. He holds two patents that showcase his innovative approach to enhancing the efficacy of therapeutic agents.
Latest Patents
Ikemoto's latest patents include a modular composition that comprises an oligonucleotide and one or more tetraGalNAc ligands. These ligands may be the same or different, and the composition may also include linkers and various targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents. This invention aims to improve the delivery of oligonucleotides, making it a significant advancement in the field.
Career Highlights
Throughout his career, Ikemoto has worked with prominent companies such as Sirna Therapeutics, Inc. and Sima Therapeutics, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for drug delivery.
Collaborations
Ikemoto has collaborated with various professionals in his field, including Steven L. Colletti, enhancing the impact of his work through shared knowledge and expertise.
Conclusion
Norihiro Ikemoto's work in oligonucleotide delivery systems exemplifies the innovative spirit of modern inventors. His patents and career achievements reflect a commitment to advancing therapeutic technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile